PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
WASHINGTON, DC 20024 · IRS data through FY2024
Revenue, expenses and net assets
Revenue Expenses Net assets
| Tax year | Revenue | Expenses | Net assets |
|---|---|---|---|
| FY2024 | $521,348,217 | $578,265,057 | $158,537,255 |
| FY2023 | $483,040,082 | $426,549,040 | $210,928,967 |
| FY2022 | $568,384,699 | $574,376,853 | $151,666,708 |
| FY2021 | $609,259,357 | $588,810,520 | $116,901,726 |
| FY2020 | $573,617,938 | $550,191,718 | $93,383,579 |
| FY2019 | $526,601,050 | $505,590,709 | $77,486,565 |
| FY2018 | $459,096,153 | $447,626,111 | $43,457,518 |
| FY2017 | $455,738,725 | $463,576,374 | $22,991,641 |
| FY2016 | $270,606,605 | $280,442,377 | $37,944,123 |
| FY2015 | $220,251,342 | $224,949,269 | $50,484,631 |
| FY2014 | $208,652,106 | $207,941,637 | $42,351,339 |
| FY2013 | $204,711,986 | $202,129,760 | $83,731,994 |
| FY2012 | $204,219,082 | $206,117,606 | $49,803,236 |
| FY2011 | $204,851,231 | $201,124,812 | $52,633,538 |
Where the revenue came from
| Source | Amount | % of revenue |
|---|---|---|
| Contributions & grants | $1,116,000 | 0% |
| Program service revenue | $507,993,172 | 100% |
What the numbers show
- Program service revenue made up 100% of total revenue in FY2024.
- Net assets covered about 3.3 months of expenses at the end of the reporting year.
- Total revenue rose from $204,851,231 in FY2011 to $521,348,217 in FY2024, Revenue increased in 10 and decreased in 3 of 13 year-over-year comparisons.
- Expenses exceeded revenue in 6 of 14 reported years (FY2012, FY2015, FY2016, FY2017, FY2022, FY2024).
- The highest revenue on record here is $609,259,357 in FY2021.
- Net assets grew from $52,633,538 to $158,537,255 between FY2011 and FY2024.
Figures compared against other organizations of the same NTEE program area in the same state. See the methodology page for how these are calculated and the guide to reading nonprofit financials for their limits.
About this organization
PHRMA'S MISSION IS TO CONDUCT EFFECTIVE ADVOCACY FOR PUBLIC POLICIES THAT ENCOURAGE THE DISCOVERY OF IMPORTANT NEW MEDICINES FOR PATIENTS BY BIOPHARMACEUTICAL RESEARCH COMPANIES.
IRS status
| Ruling year | 1959 |
| Subsection | 501(c)(6) |
Source: Internal Revenue Service — Exempt Organizations Business Master File (downloaded September 20, 2026), Statistics of Income extracts, Form 990 e-file data, Publication 78 and the Automatic Revocation list. Figures are as reported by the organization; IRS processing may adjust them. This is not a charity rating and not tax advice. Confirm deductibility in IRS Tax Exempt Organization Search.
Think something here is wrong or should be removed? Use the contact form — we act on removal requests within 30 days.